About this trial
To explore associations with demographics/clinical factors; assess trajectories via annual follow-up; evaluate healthcare utilization and barriers; oversample \>10-year survivors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥40 years with no upper age restriction, provided performance status permits procedural candidacy
Symptomatic mild-to-severe knee osteoarthritis (Kellgren-Lawrence grade 2-4) on radiographs within 6 months of enrollment
Chronic knee pain (NRS ≥4/10) for ≥3 months despite conservative treatment including steroid injections, physical therapy, and/or analgesic medications
Inadequate candidate for or refusal of surgical intervention (e.g., total knee arthroplasty) due to cancer-related comorbidities, ongoing treatment, or participants preference
Disqualifiers
Active joint infection or suspected septic arthritis
Life expectancy <6 months
Prior knee arthroplasty in the index knee
Coagulopathy or contraindications to angiography
Trial population
UT MD Anderson Cancer Center
Trial design
Cohort
Prospective
Treatments tested in this trial
SOC (Standard of care)
Other interventionPatients scheduled for standard of care
Treatment groups
Trial outcomes
Primary outcomes
Numeric Rating Scale Questionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.